Understanding how cells turn genes on and off is one of biology's most enduring mysteries. Now, a new technology developed by ...

A better understanding of protein glycosylation offers insights into disease mechanisms and helps improve therapeutic medicines.

Latus Bio, Inc. (Latus), a biotechnology company pioneering advances in adeno-associated virus (AAV) gene therapy, today ...

Arabidopsis thaliana was always an unlikely candidate for the limelight. But 25 years ago, the diminutive thale cress ...

Researchers have created a detailed map of chemical modifications to DNA that occur in the human brain from the earliest ...

Within each cell, there is a constant struggle between life-sustaining molecules and molecules that could hasten its demise.

Investigators at Weill Cornell Medicine have developed a versatile and non-toxic technology for controlling the activity of ...

A naturally occurring gene called Cyclin A2 (CCNA2), which turns off after birth in humans, can actually make new, functioning heart cells and help the heart repair itself from injury, including a ...

A new genomic method has enabled multiple people with rare conditions to receive diagnoses that were previously unattainable ...

A team of scientists has developed a highly accurate blood test for Chronic Fatigue Syndrome. The test reads tiny DNA patterns that reveal the biological signature of the illness. For millions who’ve ...

A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes ...